Repligen Corp (RGEN)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$112.00

Buy

$118.00

arrow-down$-0.54 (-0.46%)

Prices updated at 02 Apr 2026, 22:59 EDT

Prices minimum 15 mins delay

Prices in USD

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

NASDAQ

0.18%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	634m	738m
	275m	386m
	-32m	42m
	-5.03	5.63
	-26m	49m
	80m	181m
Sales, General and administrative	263m	291m
Interest expenses	21m	22m
Provision for income taxes	-2m	13m
Operating expenses	307m	345m
Income before taxes	-27m	62m
Net income available to common shareholders	-26m	49m
	-0.46	0.87
Net interest income	-23m	-23m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-0.46	0.86
Free cash flow per share	2.3475	1.8421
Book value/share	35.9534	36.9831
Debt equity ratio	0.340212	0.317354

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	1,066m	1,137m
Current liabilities	127m	136m
Total capital	2,498m	2,648m
Total debt	686m	690m
Total equity	1,973m	2,106m
Total non current liabilities	-	-
Loans	526m	542m
Total assets	2,830m	2,950m
Total liabilities	-	-
Cash and cash equivalents	757m	566m
Common stock	56m	56m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	751m	757m
Cash dividends paid	-	-
	142m	92m
Investments (gains) losses	-86m	-298m
	757m	566m
Net income	-	-
	175m	117m
	-33m	-26m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.